RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Myriad Genetics Stock

Myriad Genetics Equity 2025

Myriad Genetics Equity

701.1 M USD

Ticker

MYGN

ISIN

US62855J1043

WKN

897518

In 2025, Myriad Genetics's equity was 701.1 M USD, a -10.48% increase from the 783.2 M USD equity in the previous year.

Myriad Genetics Aktienanalyse

What does Myriad Genetics do?

Myriad Genetics Inc. is a biotechnology company specializing in the research of cancer and genetic analysis technologies. The company was founded in 1991 by Mark Skolnick and has since become a global leader in personalized medicine and diagnostics. It is headquartered in Salt Lake City, Utah, USA, and employs over 2,400 employees worldwide. Myriad Genetics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Myriad Genetics's Equity

Myriad Genetics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Myriad Genetics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Myriad Genetics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Myriad Genetics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Myriad Genetics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Myriad Genetics stock

What is the equity of Myriad Genetics this year?

Myriad Genetics has equity of 701.1 M USD this year.

What was the equity of Myriad Genetics compared to the previous year?

The equity of Myriad Genetics has increased/decreased by -10.48% decreased compared to the previous year.

What impact does a high equity have on investors of Myriad Genetics?

A high equity is advantageous for investors of Myriad Genetics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Myriad Genetics?

A low equity can be a risk for investors of Myriad Genetics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Myriad Genetics affect the company?

An increase in equity of Myriad Genetics can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Myriad Genetics affect the company?

A reduction in equity of Myriad Genetics can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Myriad Genetics?

Some factors that can affect the equity of Myriad Genetics include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Myriad Genetics so important for investors?

The equity of Myriad Genetics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Myriad Genetics take to change the equity?

To change equity, Myriad Genetics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Myriad Genetics pay?

Over the past 12 months, Myriad Genetics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Myriad Genetics is expected to pay a dividend of 0 USD.

What is the dividend yield of Myriad Genetics?

The current dividend yield of Myriad Genetics is .

When does Myriad Genetics pay dividends?

Myriad Genetics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Myriad Genetics?

Myriad Genetics paid dividends every year for the past 0 years.

What is the dividend of Myriad Genetics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Myriad Genetics located?

Myriad Genetics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Myriad Genetics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Myriad Genetics from 5/30/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/30/2025.

When did Myriad Genetics pay the last dividend?

The last dividend was paid out on 5/30/2025.

What was the dividend of Myriad Genetics in the year 2024?

In the year 2024, Myriad Genetics distributed 0 USD as dividends.

In which currency does Myriad Genetics pay out the dividend?

The dividends of Myriad Genetics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Myriad Genetics

Our stock analysis for Myriad Genetics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Myriad Genetics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.